Skip to content
naulon
Get started
Not checkedNot checked for notices yet.

Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy

Caroline Robert, Rui Jiang, Pierre-Antoine Laurent and 14 more

Journal for ImmunoTherapy of Cancer · 2022

doi:10.1136/jitc-2022-004867 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References30

  1. 6.
    Corrected

    Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI · 2017

  2. 20.

    A decade of immune-checkpoint inhibitors in cancer therapy · 2020

28 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.